EX-10.13



 Exhibit 10.13 

April 1, 2014 
 Chris Bowden, M.D. 

736 Sequoia Valley Rd 
 Mill Valley 

CA 94941 
 Dear Chris, 

I am pleased to offer you the position of Chief Medical Officer at Agios Pharmaceuticals, Inc. (the “Company”) reporting to David Schenkein, Chief
Executive Officer. This letter agreement (this “Offer Letter”) outlines the terms and conditions of your employment. You will receive a semi-monthly salary of $16,458.34 which is equivalent to $395,000.16 annually. 

You will also receive a one-time payment in the amount of $120,000.00. This payment will be made as part of the normal semi-monthly payroll after 30 days of
employment. In addition, upon the later of one year of service or your relocation to MA, you will receive another one-time payment in the amount of $150,000.00. This payment will also be made as a part of the normal semi-monthly payroll assuming you
are an employee in good standing at the time of payment. If you voluntarily leave the Company within 18 months of receiving either payment you will be required to repay the full amount(s). All payments will be subject to legally required tax
withholdings. 
 You will be eligible for our Bonus Program. If the Company meets or exceeds its annual goals, a pool will be established for employees
which will be subject to approval by the Board of Directors. This pool will be allocated according to level and annual review rating. Your individual payment may be pro-rated based on the amount of time you worked at Agios in the prior calendar
year. 
 You will be granted a stock option to purchase 120,000 shares of the Company’s common stock, subject to approval by our Board of Directors or
their designated representative. The stock option exercise price will be the closing price of AGIO stock on the date of grant and will be subject to the standard terms and conditions of the Company 2013 Stock Incentive Plan (the “Plan”).
The option will vest over four years at the rate of 25% after twelve months of full time active employment and then an additional 1/48th for each additional month of full time active employment
after your first anniversary date until after four full years when the option is fully vested. A copy of the Plan will be provided to you along with a Stock Option Grant Letter after the option grant has been approved. 

Upon a Change of Control (as defined below), the vesting of the options, restricted stock and/or other stock-based equity awards held by you (collectively
“Shares”) shall be accelerated in part, such that 75% of the then unvested Shares shall immediately vest. The remaining 25% 







 
of the unvested Shares shall vest according to the schedule (i.e., with fewer Shares vesting over the same time period) set forth in the applicable stock option agreement, restricted stock
agreement or other similar equity agreement (collecively, “Equity Agreements”). If, upon or within 18-months following a Change of Control, your employment is terminated by the Company without Cause (as defined below) or by you for Good
Reason (as defined below), the vesting of your Shares shall accelerate in full, such that all of your Shares shall immediately vest as of the date of such termination of emloyment. For purposes of this Offer Letter, “Change of Control”
shall mean the sale of all or substantially all of the outstanding shares of capital stock, assets or business of the Company, by merger, consolidation, sale of assets or otherwise (other than a transaction in which all or substantially all of the
individuals and entities who were beneficial owners of the capital stock of the Company immediately prior to such transaction beneficially own, directly or indirectly, more than 50% of the outstanding securities (on an as-converted to common stock
basis) entitled to vote generally in the election of directors of the (i) resulting, surviving or acquiring corporation in such transaction in the case of a merger, consolidation or sale of outstanding shares, or (ii) acquiring corporation
in the case of a sale of assets). 
 You will be eligible to participate in all of the Company’s benefits plans, which include Medical and Dental
Insurance Programs, Flexible Spending Program for medical and daycare expenses, Life Insurance, AD&D, and Short and Long Term Disability Plans, and 401(k). The Company pays for 90% of the cost of the HMO medical plan and 85% of the PPO plan. It
pays for 90% of the cost of the dental plan and will pay the full cost of Life and AD&D insurance as well as Short and Long Term Disability plans. You will accrue three weeks paid vacation each year and receive 11 paid holidays annually in
accordance with the Company holiday schedule. 
 The offer of employment is contingent upon your signing the Company’s standard Forms of Agreement
Regarding Inventions, Confidentiality and Non-Competition (Copy attached) and I-9 Employment Verification Form. You will be required to submit documentation that establishes identity and employment eligibility in accordance with the US Immigration
and Naturalization requirements. If there are any other agreements of any type that you are aware of which may impact or limit your ability to perform your job at the Company, please let us know as soon as possible. 

This Offer Letter is not intended to create or constitute an employment agreement or contract between you and the Company. It is also important for you to
understand that Massachusetts is an “at will” employment state. This means that you will have the right to terminate your employment relationship with the Company at any time for any reason. Similarly, the Company will have the right to
terminate its employment relationship with you at any time for any reason. 
 Without otherwise limiting the “at-will” nature of your employment,
in the event your employment is terminated at any time by the Company without Cause or by you for Good Reason (a) the Company will continue to pay you your then-current base salary payable in accordance with the Company’s regular payroll
practice for a period of twelve (12) months commencing on the Payment Date (as defined below), (b) you will receive your annual incentive bonus to the extent otherwise payable during such 12-month period payable in a








 
lump sum when annual incentive bonuses are paid to other members of senior management of the Company but, in any event, no later than March 15 of the year following the year in which the
Board of Directors (or its designee) approves the payment of such bonuses to members of senior management of the Company, (c) you will be entitled to 12 months of continuation of health and dental insurance consistent with the current plans
provided by the Company and payable in accordance with the Company’s regular payroll practice with respect to benefits and (d) if such termination occurs prior to a Change of Control, the vesting of your Shares shall be accelerated in
part, such that a number of Shares equal to 25% of the original number of Shares subject to each of your Equity Agreements shall immediately vest (or if the number of unvested Shares subject to any such Equity Agreement is less than 25% of the
original award subject to such Equity Agreement, then all remaining unvested Shares subject to such Equity Agreement shall immediately become fully vested). No severance payments or acceleration of vesting shall be paid under this Offer Letter
unless you first execute and do not revoke a waiver and release within 45 days following the date of termination, which provides for a release of any and all claims that you have or might have against the Company. The severance payments and
acceleration of vesting shall be paid or commence on the first payroll period following the date the waiver and release becomes effective (the “Payment Date”). Notwithstanding the foregoing, if the 45th day following the date of termination occurs in the calendar year following the calendar year of the termination, then the Payment Date shall be no earlier than January 1 of such subsequent
calendar year. 
 For the purposes of this Offer Letter, the Company shall have “Cause” for termination upon: (a) a finding by the
Company’s Board of Directors, in its reasonable discretion, that you have engaged in dishonesty, misconduct or gross negligence; (b) the conviction of you, or the entry of a pleading of guilty or nolo contendere by you to, any crime
involving moral turpitude or any felony; or (c) a material breach of any agreement between you and the Company. 
 For purposes of this Offer Letter,
“Good Reason” shall mean the occurrence of any of the following events without your prior written consent: 
 (a) a material
diminution in your base compensation; 
 (b) a material diminution in your authority, duties or responsibilities (this determination will
include an analysis of whether you maintain at least the same level, scope and type of duties and responsibilities with respect to the management, strategy, operations and business of the Company); or 

(c) a material change in geographic location at which you perform services (if your new one-way commute is more than thirty five
(35) miles greater than your one-way commute prior to the change in your principal work location, regardless of whether you receive an offer of relocation benefits, such change shall be deemed material hereunder); 

provided, however, that no such event or condition shall constitute Good Reason unless (x) you give the Company a written notice of
termination for Good Reason not more than 30 days after the initial existence of the condition, (y) the grounds for termination (if susceptible to correction) are not corrected by the Company within 30 days of its receipt of such
notice and (z) your termination of employment occurs within two months following the Company’s receipt of such notice. 







 Any severance payments or benefits provided to you pursuant to this Offer Letter shall begin only after the date
of your “separation from service” (within the meaning of Section 409A of the Internal Revenue Code of 1986 (as amended or replaced) (the “Code”), which occurs on or after date of the termination of your employment, and shall
be subject to the following provisions: 
 (i) It is intended that each installment of the severance payments and benefits shall be treated
as a separate “payment” for purposes of Section 409A of the Code. Neither the Company nor you shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or
required by Section 409A. 
 (ii) If, as of the date of your “separation from service” from the Company, you are not a
“specified employee” (within the meaning of Section 409A), then each installment of the severance and benefits payments shall be made on the dates and terms set forth in this Offer Letter. 

(iii) If, as of the date of your “separation from service” from the Company, you are a “specified employee” (within the
meaning of Section 409A), then: 
 (A) Each installment of the severance payments and benefits, that, in accordance with the dates and
terms set forth in this Offer Letter, will in all circumstances, regardless of when the “separation from service” occurs, be paid within the short-term deferral period (as defined under Section 409A) shall be treated as a
“short-term deferral” within the meaning of Treasury Regulation Section 1.409A-l(b)(4) to the maximum extent permissible under Section 409A and shall be made on the dates and terms set forth in this Offer Letter; and 

(B) Each installment of the severance payments and benefits that is not described in clause (iii)(A) above and that would, absent this clause
(B), be paid within the six-month period following your “separation from service” from the Company shall not be paid until the date that is six months and one day after such “separation from service” (or, if earlier, your death),
with any such installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following your “separation from service” and any subsequent
installments, if any, being paid in accordance with the dates and terms set forth in this Offer Letter; provided, however, that the preceding provisions of this clause (B) shall not apply to any installment of severance payments and benefits if
and to the maximum extent that such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A-l(b)(9)(iii) (relating to separation pay
upon an involuntary separation from service). Any installments that 







 
qualify for the exception under Treasury Regulation Section 1.409A-1 (b)(9)(iii) must be paid no later than the last day of your second taxable year following the taxable year in which the
“separation from service” occurs. 
 (iv) The determination of whether and when your “separation from service” from the
Company has occurred shall be made in a manner consistent with, and based on the presumptions set forth in, Treasury Regulation Section 1.409A-I(h). Solely for purposes of this paragraph (iv), “Company” shall include all persons with
whom the Company would be considered a single employer under Section 414(b) and 414(c)of the Code. 
 (v) All reimbursements and in-kind
benefits provided under this Offer Letter shall be made or provided in accordance with the requirements of Section 409A to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable,
the requirements that (i) any reimbursement is for expenses incurred during your lifetime (or during a shorter period of time specified in this Offer Letter), (ii) the amount of expenses eligible for reimbursement during a calendar year
may not affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense will be made on or before the last day of the calendar year following the year in which the expense is incurred
and (iv) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit. 
 (vi) Notwithstanding
any other provision of this Offer Letter, the Company shall have no liability to you or to any other person if any provisions of this Offer Letter that are intended to be exempt from or compliant with Section 409A are not so exempt or
compliant. 
 [Remainder of Page Intentionally Left Blank] 







 I am very excited about having you join our team and I anticipate that you will make many important contributions
to our Company and strategic mission. Please acknowledge your agreement to the foregoing terms and conditions of your employment by returning a signed copy of this Offer Letter. This offer will remain open until April 18, 2014. 

Best regards, 
  

	
	/s/ J. Duncan Higgons
	
	J. Duncan Higgons
	Chief Operating Officer
	Agios Pharmaceuticals, Inc.

 I accept this offer of employment with Agios Pharmaceuticals Inc. and will begin work on: 

May 14, 2014. 
 Signature: 

 

							
	 /s/ Chris Bowden
	  		  	April 4, 2014	  	
	Chris Bowden	  		  	Date